UPM Institutional Repository

Liposome encapsulation: a promising approach to enhanced and safe mefenamic acid therapy


Citation

Jarrar, Qais Bashir Mahmoud and Ahmad, Zuraini and Abdul Kadir, Arifah and Zakaria, Zainul Amiruddin and Abdullah, Muhammad Nazrul Hakim (2017) Liposome encapsulation: a promising approach to enhanced and safe mefenamic acid therapy. International Research Journal of Education and Sciences, 1 (1). pp. 32-39. ISSN 2550-2158

Abstract

Mefenamic acid (MEF) is a non-steroidal anti-inflammatory drug (NSAID) characterized by low bioavailability with relative high toxicity. Despite the efforts which have been paid to enhance its bioavailability, its inherent toxicity remains the limiting factor for its medical uses. Designing MFE as a prodrug of ester derivatives can attenuate gastrointestinal (GI) toxicity, but shows no advantages in term of therapeutic efficacy. Liposomes have a dual action and would be a promising tool to enhance MFE bioavailability and reduce its gastric and systemic adverse reactions. This review covers the pharmacological and toxicological aspects of MFE and provides substantial trend to enhance its clinical therapy.


Download File

[img]
Preview
Text (Abstract)
Liposome encapsulation a promising approach to enhanced and safe mefenamic acid therapy.pdf

Download (34kB) | Preview

Additional Metadata

Item Type: Article
Divisions: Faculty of Medicine and Health Science
Faculty of Veterinary Medicine
Halal Products Research Institute
Sport Academy
Publisher: Malaysia Association of Research and Education for Educators
Keywords: Bioavailability; Mefenamic acid; Proliposome; Phospholipids; Toxicity
Depositing User: Nabilah Mustapa
Date Deposited: 01 Mar 2018 02:46
Last Modified: 01 Mar 2018 02:46
URI: http://psasir.upm.edu.my/id/eprint/59391
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item